Related Experiment Video
Updated: Dec 2, 2025

Percutaneous Contrast Echocardiography-guided Intramyocardial Injection and Cell Delivery in a Large Preclinical Model
Published on: January 21, 2018
Editorial: Cardiomyopathies: Current Treatment and Future Options
1Internal Medicine-Cardiology, Ubbo Emmius Hospital Norden, Cardiology, Osterstr. 110, 26506 Norden, Germany.
Insights
Cardiomyopathies, essential in clinical cardiology, are increasingly understood due to genetics and pathomechanism insights. This review covers current and future treatment options for these complex heart muscle diseases.
Area of Science:
- Cardiology
- Genetics
- Pathophysiology
Background:
- Cardiomyopathies represent a critical area within clinical cardiology.
- The classification and understanding of cardiomyopathies have expanded significantly.
- Advances in genetics and pathomechanism have driven this growth.
Abstract:
Cardiomyopathies are an essential component in clinical cardiology. The number of different cardiomyopathies have increased a lot due to genetics and newer insights in pathomechanism. The current treatment and future options are demonstrated in advance.
More Related Videos
08:24Establishing a Swine Model of Post-myocardial Infarction Heart Failure for Stem Cell Treatment
Published on: May 25, 2020
09:11Cell-based Therapy for Heart Failure in Rat: Double Thoracotomy for Myocardial Infarction and Epicardial Implantation of Cells and Biomatrix
Published on: September 22, 2014
Related Concept Videos
Cardiomyopathy V: Interprofessional Care
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Myocarditis III: Medical Management
Cardiomyopathy IV: Restrictive Cardiomyopathy
Cardiomyopathy VI: Nursing Management